EQS-News: Freelancer wins US$6.7m task order with NASA and the National Institutes of Health in gene editing
50%+ editing efficiency) non-viral delivery system capable of crossing the blood brain barrier to deliver genome editing machinery to a majority of target cell types in the central nervous system.
- 50%+ editing efficiency) non-viral delivery system capable of crossing the blood brain barrier to deliver genome editing machinery to a majority of target cell types in the central nervous system.
- 3+ configurations) delivery system to deliver genome editing machinery that can target specific tissues or cell types.
- It is expected that FLN will generate approximately US$700,000 in net revenue contribution for this task order.
- SCGE is developing quality tools to perform and assess effective and safe genome editing in non-reproductive (somatic) cells of the body.